Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Rankning i aktier #19166
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Aktiekurs
$1.62
Senast synkroniserad: 2026-08-25
Marknadsvärde
$172.47M
Förändring (1 dag)
-3.57%
Förändring (1 år)
446.74%
Land
US
Handel Cypherpunk Technologies Inc. (CYPH)

Kategori

Aktiekurshistorik för Cypherpunk Technologies Inc. (CYPH)
Högsta slutkurs: $0.94 den 2026-08-01

Lägsta slutkurs: $75.65 den 2017-01-01
Aktiekurshistorik för Cypherpunk Technologies Inc. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$771.23 7.19%
CH